Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Urea treatment of hyponatremia in subarachnoid hemorrhage
2024-518532-36-00Phase 2Completed
- Sponsor
- CHU Grenoble Alpes
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of urea in hyponatraemia and subarachnoid hemorrhage (SAH) (2 arms), sponsored by CHU Grenoble Alpes. Primary endpoint: Change in natraemia from baseline to day of treatment discontinuation. Started Oct 2020; status: completed.
02
Drugs
urea
03
Conditions
hyponatraemiasubarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on 2024-518532-36-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518532-36-00.